This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: 96P Exploiting metabolic reprogramming via targeting novel genetic variant in urocanate hydratase 1 in histidine catabolism as a potential therapeutic approach in the treatment of colorectal cancer, ESMO Open, March 2025, Elsevier,
DOI: 10.1016/j.esmoop.2025.104257.
You can read the full text:
The following have contributed to this page
